Authors: GOMMEREN W RENDERS J VANGOMPEL P LESAGE A LEYSEN JE JURZAK M

Citation: W. Gommeren et al., EXTENSIVE PHARMACOLOGICAL STUDY OF THE G-PROTEIN COUPLED FRACTION OF HUMAN 5-HT RECEPTORS USING AGONIST RADIOLIGAND BINDING, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 842-842

Authors: LESAGE AS WOUTERS R VANGOMPEL P HEYLEN L VANHOENACKER P HAEGEMAN G LUYTEN WHML LEYSEN JE

Citation: As. Lesage et al., AGONISTIC PROPERTIES OF ALNIDITAN, SUMATRIPTAN AND DIHYDROERGOTAMINE ON HUMAN 5-HT1B AND 5-HT1D RECEPTORS EXPRESSED IN VARIOUS MAMMALIAN-CELL LINES, British Journal of Pharmacology, 123(8), 1998, pp. 1655-1665

Authors: SCHOTTE A JANSSEN PFM GOMMEREN W LUYTEN WHML VANGOMPEL P LESAGE AS DELOORE K LEYSEN JE

Citation: A. Schotte et al., RISPERIDONE COMPARED WITH NEW AND REFERENCE ANTIPSYCHOTIC-DRUGS - IN-VITRO AND IN-VIVO RECEPTOR-BINDING, Psychopharmacology, 124(1-2), 1996, pp. 57-73

Authors: LEYSEN JE GOMMEREN W HEYLEN L LUYTEN WHML VANDEWEYER I VANHOENACKER P HAEGEMAN G SCHOTTE A VANGOMPEL P WOUTERS R LESAGE AS

Citation: Je. Leysen et al., ALNIDITAN, A NEW 5-HYDROXYTRYPTAMINE(1D) AGONIST AND MIGRAINE-ABORTIVE AGENT - LIGAND-BINDING PROPERTIES OF HUMAN 5-HYDROXYTRYPTAMINE(1D-ALPHA), HUMAN 5-HYDROXYTRYPTAMINE(1D-BETA), AND CALF 5-HYDROXYTRYPTAMINE(1D) RECEPTORS INVESTIGATED WITH [H-3] 5-HYDROXYTRYPTAMINE AND [H-3] ALNIDITAN, Molecular pharmacology, 50(6), 1996, pp. 1567-1580

Authors: LESAGE AS VANASSOUW H VANGOMPEL P CIK M LEYSEN J

Citation: As. Lesage et al., EVALUATION OF SEVERAL IN-VITRO AND IN-VIVO MODELS FOR OXIDATIVE STRESS, Journal of neurochemistry, 66, 1996, pp. 33-33

Authors: DEBACKER MD GOMMEREN W MOEREELS H NOBELS G VANGOMPEL P LEYSEN JE LUYTEN WHML

Citation: Md. Debacker et al., GENOMIC CLONING, HETEROLOGOUS EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF A HUMAN HISTAMINE H1-RECEPTOR, Biochemical and biophysical research communications, 197(3), 1993, pp. 1601-1608